Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

MXCT

+ Watchlist+ Portfolio

MaxCyte, Inc.

Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$1.25
52-Week Range
$0.64 – $1.80
Market Cap
$132.16M
P/E (TTM)
—
EPS (TTM)
-0.26
Dividend Yield
0.00%
Advanced Metrics
Price/Book
0.88
PEG Ratio
—
Return on Equity
-16.90%
Return on Assets
-9.28%
Gross Margin
80.98%
Operating Margin
-85.47%
Profit Margin
-81.40%
Current Ratio
7.83
Debt/Equity
0.11
Total Debt
$16.89M
Free Cash Flow
$-14.98M
Revenue Growth
48.70%
Earnings Growth
—
Enterprise Value
$44.67M

Market Snapshot

About

MaxCyte develops and commercializes cell-engineering platforms using proprietary electroporation technology for loading cells with biomolecules. The company enables biopharmaceutical developers to create cell-based therapeutics including CAR-T and other immunotherapies.